• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 PEGINTRON (peginterferon alfa-2b) Vials

 Status: Discontinuation

 » Therapeutic Categories: Antiviral

Merck Sharp & Dohme Corp. (New 09/24/2015)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
PEGINTRON (peginterferon alfa-2b) injection, 80 mcg per 0.5 mL (NDC 00085-4354-01) 09/24/2015 For business reasons, Merck has decided to voluntarily discontinue the manufacture of PEGINTRON vials, Injection, for subcutaneous use, for distribution in the United States, effective date of February 1, 2016.
PEGINTRON (peginterferon alfa-2b) injection, 120 mcg per 0.5 mL (NDC 00085-4355-01) 09/24/2015 For business reasons, Merck has decided to voluntarily discontinue the manufacture of PEGINTRON vials, Injection, for subcutaneous use, for distribution in the United States, effective date of February 1, 2016.
PEGINTRON (peginterferon alfa-2b) injection, 150 mcg per 0.5 mL (NDC 00085-4356-01) 09/24/2015 For business reasons, Merck has decided to voluntarily discontinue the manufacture of PEGINTRON vials, Injection, for subcutaneous use, for distribution in the United States, effective date of February 1, 2016.
-
-